SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
SUDOSCAN is a medical device that offers a stimulation of the sweat glands that assess small nerve fibers
Impeto Medical is a privately owned medical device company created in June 2005. Its corporate headquarters are located in Paris, France.
Impeto Medical complies with State and Federal regulations regarding the manufacture and sale of SUDOSCAN and EZSCAN.
An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy.
Simple results obtained in 3 minutes.